Search Results
Jan 07, 2026, 07:00 ET Mediar Therapeutics Announces Oversubscribed $76 Million Series B Financing and Clinical Advancement of First-in-Class Fibrosis Portfolio
Real Estate Trust (ARE), and existing Series A investors. Joining the Mediar board from Amplitude Ventures is Bharat Srinivasa, PhD, and from ICG is Allan Marchington, PhD. Proceeds from the financing will further support advancement of Mediar's wholly owned assets, including MTX-474, an antagonist of
More news about: Mediar Therapeutics
Jan 07, 2026, 03:30 ET Lonza's Synaffix and Sidewinder Therapeutics Announce Multi-Target License Agreement to Advance Development of Next-Generation Bispecific ADCs
potential in maximizing tumor targeting, hence delivering new life-saving therapies for the benefit of patients with cancer."Eric Murphy, PhD, Co–Founder and Chief Executive Officer of Sidewinder Therapeutics, said: "The ADC field has reached an exciting moment fueled
More news about: Synaffix
Jan 06, 2026, 19:43 ET Court Rejects HHS's Motion to Dismiss Lawsuit Brought by Leading Public Health Groups Against HHS Immunization Schedule Changes, ACIP Reconstitution
to these unprecedented changes to the childhood immunization schedule.Plaintiff and Attorney StatementsAndrew D. Racine, MD, PhD, FAAP, President, American Academy of Pediatrics (Lead Plaintiff):"Today's ruling moves our case forward and reinforces our commitment to
Jan 06, 2026, 15:37 ET The Inner Circle acknowledges, Rachel L. Ivory as a Pinnacle Professional Member Inner Circle of Excellence
both government and academia. She holds a bachelor's degree in criminal justice from Radford University, a master's in public administration, and a PhD in public policy and public administration from Walden University in 2017. Her doctoral dissertation, "Combat Service and Posttraumatic Stress Disorder
More news about: The Inner Circle
Jan 06, 2026, 15:33 ET National Sleep Foundation Highlights its SleepMark™ Education Program at CES
CES Show Day Media Briefing. The briefing also featured key announcements from NSF's SleepTech® Network members including Caitlin Shure, PhD, Head of Product & Content at NextSense and Kimi Doan, Chief Innovation Officer at Earable® Neuroscience.For more information about
More news about: National Sleep Foundation
Jan 06, 2026, 13:27 ET Aperture Therapeutics Announces First-In-Class MMP9 Antisense Oligonucleotide Program for ALS
failed due to fundamental limitations of small molecules and antibodies, including poor selectivity and off-target toxicity." said Martin Jacko, PhD, Founder and CEO of Aperture Therapeutics. "By directly suppressing MMP9 at the RNA level, our antisense approach is designed to overcome these historical
More news about: Aperture Therapeutics
Jan 06, 2026, 12:30 ET LMU Names Kathleen Weaver, Ph.D. Executive Vice President and Provost
multimedia:https://www.prnewswire.com/news-releases/lmu-names-kathleen-weaver-phd-executive-vice-president-and-provost-302654090.htmlSOURCE
More news about: Loyola Marymount University
Jan 06, 2026, 12:18 ET New Study Finds Millions of Americans With Heart Failure Are Not Receiving Proven, Life-Saving Therapy
evidence-based treatment could have a meaningful impact on both patient outcomes and healthcare spending."This is a solvable problem," said Julie Scherer, PhD, Chief Solutions Officer at Motive, who was directly involved in the recent study. "We consistently see geographic variation in physician performance,
More news about: Motive Medical Intelligence
Jan 06, 2026, 12:00 ET Mind With Heart Robotics Showcases Emotionally Intelligent Robot Lineup at CES 2026, Including CES Innovation Award Honoree An'An Biomimetic Affective AI Panda
distinct emotional and therapeutic needs."Dr. Zhang has over a decade of research in affective computing and human–robot interaction. Holding a PhD from the University of Sheffield, he has led over 20 robotic systems and filed more than 30 patents in biomimetic design and emotional AI—expertise that
More news about: Mind with Heart Robotics Co., Ltd.
Jan 06, 2026, 11:48 ET UBC Acquires Evidinno Outcomes Research, Expanding RealWorld Evidence and HEOR Capabilities
marks an important step in expanding the reach and influence of Evidinno's scientific and methodological expertise," said Dr. Mir Sohail Fazeli, MD, PhD, Chief Executive Officer of Evidinno. "By combining our HTA- and regulatory-grade evidence synthesis solutions, real-world research, and economic modeling
More news about: United BioSource LLC
Jan 06, 2026, 11:00 ET Novoron Bioscience Awarded $2.5 Million NIH/NIA SBIR Grant to Accelerate Alzheimer's Drug Discovery with Human Brain Organoids
efficacy and safety signals."This award allows us to put human biology at the center of Alzheimer's drug discovery," said Travis Stiles, PhD, CEO and CSO of Novoron Bioscience. "Our organoid platform gives us a more reliable way to identify compounds that interrupt tau spread. We aim to generate
More news about: Novoron Bioscience
Jan 06, 2026, 10:00 ET JOURNAL OF TRANSLATIONAL MEDICINE PUBLISHES PAPER HIGHLIGHTING POTENTIAL OF THE ELEPHAS LIVE™ PLATFORM TO TRANSFORM IMMUNOTHERAPY OUTCOMES
year in the second half of 2026."The collaboration brought together an exceptional group of leaders in immuno-oncology," said Hinco Gierman, PhD, Chief Scientific Officer at Elephas and co-author of the study. "For the first time, we demonstrate our novel approach can accurately measure response
More news about: Elephas
Jan 06, 2026, 09:30 ET Lung Cancer Research Foundation Announces Additional 2025 Scientific Research Grant Awards
survival for people with lung cancer is our priority.""It is gratifying to be able to fund even more innovative projects," said Kathryn O'Donnell, PhD, chair of LCRF's Scientific Advisory Board and Associate Professor, Molecular Biology, UT Southwestern Medical Center. "With this year's grants, LCRF's
More news about: Lung Cancer Research Foundation
Jan 06, 2026, 09:26 ET Gilgamesh Pharma Announces Positive Topline Phase 2a Results for Blixeprodil (GM-1020) in Major Depressive Disorder
study are particularly compelling as blixeprodil demonstrates both impressive efficacy and a favorable safety profile," said Dr. Gerard Sanacora, MD, PhD, Director of the Yale Depression Research Program at Yale University School of Medicine and member of the Gilgamesh Scientific Advisory Board. "The potential
More news about: Gilgamesh Pharma
Jan 06, 2026, 09:15 ET Illumina launches powerful software for connected, intuitive, and scalable multiomic analysis
Anschutz Medical School, oncology researchers used the technology to uncover new insights on melanoma through analysis of proteomic data. Kasey Couts, PhD, co-director of the CU Center for Rare Melanomas said, "I'm not a programmer, but the software is incredibly user-friendly. I don't need an extensive
More news about: Illumina, Inc.
Jan 06, 2026, 09:02 ET New Year, New Savings: Young Savers are Avoiding the Mistakes Older Savers Regret - You Can Too
saving," said Eric Ludwig, PhD, CFP®, Director of the Center for Retirement Income at The American College. "Building the habit early – even with modest contributions – sets the foundation
More news about: Nationwide
Jan 06, 2026, 09:00 ET Inizio Ignite Sparks a New Era of Connected Advisory Solutions
Advisory capabilities to create one of the largest and most specialized advisory partners in the sector. With more than 1,000 experts, including 100 PhD, PharmD, and MDs across more than 50 countries, Inizio Ignite advises clients across more than 20 therapy and disease areas and has partnered on 1,100
More news about: Inizio
Jan 06, 2026, 09:00 ET Top Five Health Care Trends for 2026: How New Technology Is Transforming Patient Care
increasingly looking for care that fits their lives, supports long-term health and reflects their individual needs," said AANP President Valerie Fuller, PhD, DNP. "From new technologies to lifestyle-focused care and expanded access points, nurse practitioners help patients navigate the next chapter of their
More news about: American Association of Nurse Practitioners (AANP)
Jan 06, 2026, 09:00 ET BillionToOne Announces Selection of Northstar Select® as the new liquid biopsy test for LC-SCRUM-TRY clinical study at National Cancer Center Hospital East
cancer patients in Japan, and we are excited to launch the next phase of LC-SCRUM-TRY through our collaboration with BillionToOne," said Koichi Goto, MD, PhD (Deputy Director, NCCHE). "By integrating the highly sensitive Northstar Select liquid biopsy into the study, we expect to find more opportunities to
More news about: BillionToOne
Jan 06, 2026, 09:00 ET The Reeve Foundation and Spinal Research Award New Grants to Advance Traumatic Spinal Cord Injury Treatments
Michael Fehlings, MD, PhD, FRCSC, FACS, Professor of Neurosurgery and Co-Director of the Spinal Program at the University of Toronto, will advance a new stem cell–based strategy
More news about: Christopher & Dana Reeve Foundation
Jan 06, 2026, 08:54 ET EyeContactDX Engages Renowned Developmental Pediatrician Dr. Carol Weitzman as Senior Strategic Advisor to Advance AI-Driven ASD Screening
and accessible screening tool."We are at a pivotal moment where AI and Digital Health intersect with routine pediatric care," said Aryeh Taub, PhD, CEO of EyeContactDX. "Dr. Weitzman's profound understanding of the challenges faced by primary care providers, combined with her involvement in the
More news about: EyeContactDX
Jan 06, 2026, 08:48 ET Leaf & Mineral™ Helps With Dry Skin When Cleaning in Cold Weather
developed for real homes and everyday use. They were formulated by a team led by a PhD-level organic chemist to deliver high performance while using plant-based surfactants, essential minerals, and unscented and dermatologist-mindful fragrance
More news about: Leaf & Mineral
Jan 06, 2026, 08:39 ET Leaf & Mineral™ Launches New Website Ahead of 2026 US Expansion
PhD-level organic chemist. At the same time, they use plant and mineral-based technology and ingredients, ensuring that every ounce of cleaner is biodegradable,
More news about: Leaf & Mineral
Jan 06, 2026, 08:34 ET GBI Biomanufacturing Announces the Appointment of Jesse McCool, Ph.D. as President
multimedia:https://www.prnewswire.com/news-releases/gbi-biomanufacturing-announces-the-appointment-of-jesse-mccool-phd-as-president-302653865.htmlSOURCE
More news about: GBI Biomanufacturing
Jan 06, 2026, 08:30 ET 'Scripting Possibilities' in Biotechnology: Global Innovators Converge in San Francisco for GenScript's 5th Annual Biotech Forum During JPM Week
keynote speakers whose work is redefining the boundaries of science, computation, and therapeutic innovation:David Baker, PhD, Director, Institute for Protein Design; Professor of Biochemistry, University of Washington; Investigator, Howard Hughes Medical Institute; Nobel
More news about: GenScript Biotech Corporation